Related Experiment Video
Updated: May 15, 2026
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Amphetamine and methamphetamine have a direct and differential effect on BV2 microglia cells
R A Shanks1, J R Anderson, J R Taylor
1Department of Biology, Department of Psychology, North Georgia College and State University, 82 College Circle, Dahlonega, GA 30597, USA. rashanks@northgeorgia.edu
Bulletin of Experimental Biology and Medicine
|January 19, 2013
Summary
Methamphetamine, unlike amphetamine, impairs microglial phagocytosis and alters cytokine regulation in BV2 cells. This study reveals distinct cellular responses to these stimulants, impacting immune function.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglia are the primary immune cells of the central nervous system.
- Stimulant drugs like amphetamine and methamphetamine can impact neuroinflammation.
- Understanding drug effects on microglia is crucial for neurological health.
Purpose of the Study:
- To compare the direct effects of amphetamine and methamphetamine on BV2 microglia cells.
- To investigate the influence of cellular debris on these drug-induced effects.
- To analyze the impact on microglial phagocytosis and cytokine production.
Main Methods:
- Exposure of BV2 microglia cells to varying concentrations of amphetamine and methamphetamine.
- Assessment of phagocytic activity in the presence and absence of cellular debris.
- Quantification of differential cytokine regulation following drug treatment.
Main Results:
- A significant dose-dependent and treatment-dependent effect was observed.
- Methamphetamine, but not amphetamine, significantly inhibited microglial phagocytosis.
- Differential regulation of cytokines was noted in response to amphetamine and methamphetamine exposure.
Conclusions:
- Methamphetamine exerts distinct inhibitory effects on microglial phagocytosis compared to amphetamine.
- Both drugs differentially regulate cytokine production by microglia.
- These findings highlight the specific neuroimmune impacts of methamphetamine and amphetamine.
Related Concept Videos
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...